Article Details

NC Biotech board member is new head of R&D, CMO at biopharma innovator Intercept

Retrieved on: 2021-06-18 11:03:45

Tags for this article:

Click the tags to see associated articles and topics

NC Biotech board member is new head of R&D, CMO at biopharma innovator Intercept. View article details on hiswai:

Excerpt

Michelle Berrey, M.D.. Most recently, she was the president and chief executive officer of Chimerix, a Durham-based biopharmaceutical company that ...

Article found on: www.wraltechwire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up